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Papillary fibroelastomas are rare primary tumours of cardiac origin accounting for approximately 10% of all primary
cardiac neoplasms. Due to a high thromboembolic risk, surgical excision is the mainstay of treatment in these
patients and median sternotomy the most widely used approach. We describe the case of a 43 year-old lady
presenting with acute myocardial infarction secondary to aortic valve papillary fibroelastoma subsequently excised
using a minimal access technique. From our experience mini-sternotomy offers excellent exposure and allows for
safe resection in such cases, improving cosmesis without compromising either intra or post-operative outcome.
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Papillary fibroelastomas (PFE) are rare primary tumours of
cardiac origin accounting for approximately 10% of all pri-
mary cardiac neoplasms [1]. They may occur anywhere on
the endocardium, although are more common in the left
heart and display a predilection for valvular structures.
The aortic valve is the most commonly affected, with a
number of such tumours arising from the non-coronary
leaflet [2,3]. Whilst the majority are incidental findings on
echocardiography, symptoms most commonly occur sub-
sequent to embolisation, and may give rise to a wide var-
iety of presenting features including neurological events
(transient ischaemic attack, stroke, amaurosis fugax, spinal
cord infarction) [4-6], acute coronary syndrome [7,8], and
distal thromboembolism [9]. More rarely, cardiac conduc-
tion abnormalities, direct coronary ostial occlusion and
outflow tract obstruction (in ventricular PFE) have been
reported [10,11].
Macroscopically, papillary fibroelastomas are charac-
terised by multiple frond-like fibrous projections creating
a ‘sea anemone’ appearance when immersed in saline.* Correspondence: leanne.harling@imperial.ac.uk
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reproduction in any medium, provided the orHistologically, the tumour is comprised of an avascular
fibroelastic core, made up of a hyalinised collagen matrix
with a rim of smooth muscle cells and elastic fibres, lined
by endocardial endothelium [12,13]. Immunohistochem-
ical characteristics include positive staining for factor VIII-
related antigen, CD34 and Vimentin confirming a vascular
endothelial cell lining, and multilayered type IV collagen
elastic proliferation deep to the surface membrane [14].
The aetiology of PFE remains largely unknown [3]. Re-
cent hypotheses include fibroblast infiltration with or-
ganisation of mural thrombi [15], viral induced tumour
growth [13], and an endothelial response to cardiac sur-
gery, mechanical trauma or thoracic radiation [16,17].
Historically, PFE has also been described as both a true
neoplasm and a hamartomatous lesion [18], whereas
some authors have suggested they are merely an over-
growth of Lambl’s excrescences [19].
Over recent years, there has been an increase in the num-
ber of reports of minimally invasive, thoracoscopic and even
robotic resections of aortic valve PFE (Table 1) [20-25]. A
total of 9 cases have been reported to date, of which 7 de-
scribe PFE of the AV (5 non-coronary leaflet, 2 right coron-
ary leaflet), 1 of the right atrium and 1 of the left ventricle.
Both mini-sternotomy and mini-thoracotomy approaches
(± thoracoscopic assistance) have been used with incision
size ranging from 4 to 9 cm, although it seems that mini-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Summary of published results
Reference n Age
(yrs)











Zebele 2010 [25] 1 - 0:1 Not described Non-coronary
leaflet
1.0 × 1.0 7 cm skin incision with
mini-sternotomy
- - - Not described -
Hsu 2006 [21] 4 54 ± 5 0:4 2 Embolic stroke,
1 sequential TIAs,
and 1 SOBOE &
lightheadedness
3 Non coronary
leaflet 1 R coronary
cusp
0.8 ± 0.3 × 0.65 ± 0.35 Partial sternotomy
extended into 3rd ICS.
Incision length 6.1 ± 1.4 cm














1.5 × 1.0 5 cm R anterior
thoracotomy (camera
control: AESOP 3000)
- 57 24 Uneventful recovery.






Grande 2007 [20] 1 22 1:0 Asymptomatic.
Incidental finding on `
TTE for MV prolapse
Ventricular aspect
of R coronary leaflet
0.6 × 0.9 9 cm ‘J’ incision on
midline from 3 cm below
jugular notch to 2nd ICS.
Sternum opened from
manubrium to 3rd ICS.













Diameter 1.0 Robotic: 5 cm right anterior
mini-thoracotomy 2nd ICS.
30 - 48 Discharge day 3.
No complications
at last follow up.
1
Robotic arms via stab
incisions R 1st and 3rd ICS
Cannulation: RCFA, RCFV





Right Atrium - 4 cm R anterior
mini-thoracotomy
in 4th ICS






TIA – Transient Ischaemic Attack; SOBOE – Shortness of Breath on Exertion; TTE – Trans Thoracic Echo; MV – Mitral Valve; LV – Left Ventricle; CT – Computerised Tomography; RCFA – Right Common Femoral Artery;
















Figure 1 Computerised Tomography image demonstrating
both an aortic valve lesion (black arrow) and an embolus to the
distal left anterior descending artery (white arrow).
Figure 3 Minimal access approach and set-up.
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reduced post-operative pain and less mammary scaring
when compared to mini-thoracotomy in cases of AV PFE
[26]. Whilst no long term follow up has been documented,
short term results with such procedures are encouraging
with a mean hospital stay of 4±0.57 days and no adverse
events reported prior to discharge.
In this report we review the current literature on min-
imally invasive intervention for PFE and present a case
of aortic valve PFE resected via mini-sternotomy.
Case report
A 43-year-old lady without significant co-morbidity and
no apparent cardiovascular risk factors presented to us
for a second opinion following an emergent admission
to her local hospital department with sudden onsetFigure 2 Trans-thoracic echocardiography demonstrating
mobile mass on the left coronary cusp of the aortic valve.central chest pain and ECG changes indicative of acute
anterior myocardial infarction (AMI). After initial sup-
portive medical therapy and improvement of her acute
symptoms, investigations to further characterise the na-
ture of her coronary disease were performed. CT coron-
ary angiography showed the culprit lesion was likely to
be an embolic occlusion of the distal left anterior des-
cending (LAD) artery after the second diagonal branch,
but incidentally made note of a soft tissue mass seen onFigure 4 Excised fibroelastoma.
Figure 5 Histology of the excised PFE.
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Further characterisation of this lesion by both trans-
thoracic (TTE) (Figure 2) and trans-oesophageal echo
(TOE) showed appearances consistent with a papillary
fibroelastoma (PFE) and she was admitted for surgery on
the 24th October 2011. A minimal access 6 cm skin
incision was made, and the chest entered via a limited
upper sternotomy extending to the right 3rd intercostal
space. Cannnulation was performed via the ascending
aorta and right atrium (Figure 3). Following transverseaortotomy, the aortic valve was inspected revealing a
round mass at the very edge of the left coronary cusp.
The lesion was excised, sparing the AV, and the valve
tested confirming perfect competence prior to closure.
Total cross clamp time was 16 minutes with an un-
eventful wean from bypass. Prior to decannulation,
intra-operative TOE confirmed normal valve competence
and good overall myocardial function. Total operative
time was 52 minutes. The excised lesion measured
9 × 8 × 3 mm (Figure 4). Histopathology demonstrated a
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rounded by elastic tissue covered with a layer of endocar-
dial endothelium, typical of PFE (Figure 5). The patient
had an uneventful post-operative course and was dis-
charged home 3 days after surgery.
Conclusions
The high risk of thromboembolic complications makes
urgent surgical intervention a requirement in the major-
ity of PFEs. Whilst symptomatic patients presenting with
non-mobile lesions may be treated with long-term antic-
oagulation and regular follow up, there is little data
reporting outcomes in such patients [3]. Median sternot-
omy is still the most widely used approach, however, in
the absence of other pathology requiring open cardiac
surgical intervention, there is increasing evidence that
minimally invasive techniques offer excellent exposure
and allow for safe resection, particularly in aortic PFEs.
Minimally invasive surgery boasts a number of potential
advantages including improved cosmesis, a reduction in
post-operative pain, blood loss, subsequent transfusion
and shorter intensive care unit and overall hospital stay
[27]. Consequently, such techniques may not only lead to
greater overall patient satisfaction but also improve hos-
pital resource utilisation. Conversely however, minimally
invasive surgery is associated with a steep operator learn-
ing curve and, in the case of surgical robotics, the need for
costly equipment may limit its uptake in smaller centres.
Furthermore, evidence on the optimal surgical approach
to PFE also remains limited, and it is unlikely that a rando-
mized controlled trial may ever be performed in light of
the low incidence of these tumours.
Our case demonstrates the safe application of a min-
imally invasive approach to aortic valve papillary fibroe-
lastoma without compromising cross clamp or operative
time and achieving an excellent early clinical result. We
also present increasing evidence to support the use of
minimally invasive approaches in the treatment of PFE,
particularly in the aortic position. We feel that in
selected patients with PFE minimally invasive surgery
should be the approach of choice, and where this is not
available, we advocate prompt referral to a specialist
centre with the provision and expertise to undertake a
minimal access approach.
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